Peptide aggregation: difference between revisions
Diff·revision 12 → 13·00:31, 22 Feb 2025
Difference between revision 12 and revision 13 of Peptide aggregation. 6 lines changed; the page grew by 127 bytes.
| Revision 12 — 09:54, 6 Feb 2025 LeanMassLars (talk) add the detection wavelength 3,901 bytes +786 | Revision 13 — 00:31, 22 Feb 2025 PreregPriya (talk) add the reference standard and its traceability 4,028 bytes +127 | ||
|---|---|---|---|
| 37 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 37 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| 38 | 38 | ||
| + | 39 | == See also == | |
| + | 40 | * [[Deamidation]] | |
| + | 41 | * [[Methionine oxidation]] | |
| + | 42 | * [[Lyophilisation]] | |
| + | 43 | * [[Reconstitution of lyophilised peptides]] | |
| + | 44 | ||
| 39 | {{DEFAULTSORT:Peptide aggregation}} | 45 | {{DEFAULTSORT:Peptide aggregation}} |
| 40 | [[Category:Peptide degradation]] | 46 | [[Category:Peptide degradation]] |